Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07206810) titled 'A Study of the Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients' on Sept. 26.

Study Type: Observational [Patient Registry]

Primary Sponsor: The First Affiliated Hospital of Soochow University

Condition: Myeloma

Intervention: Drug: Bortezomib, Lenalidomide, and Dexamethasone

Recruitment Status: Not recruiting

Date of First Enrollment: August 1, 2018

Target Sample Size: 419

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07206810

Published by HT Digital Content Services with permission from Health Dail...